Scratch assays showed that miR‐1208 inhibitors could eliminate the inhibition of sh‐circPUM1 on the migration of HCC cells, whereas MAP3K2 knockdown (MAP3K2 siRNA) could reverse this process (Figure 6A). Here, MAP3K2 is linked to hepatocellular carcinoma.